Monday, May 23, 2011
Stem cells heading somewhere in a gift basket
A reverse merger between VistaGen Therapeutics and Excalibur Enterprises slaps a bow on a Jekyll-and-Hyde month for the stem cell industry. Who is Excalibur? Another stem cell company? A group of Arthurian-minded investors expecting to pull stem cells from the Wall Street stone? None of the above.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment